Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies

Y Sherer1, R Gerli, B Gilburd

  • 1Department of Medicine B and Center of Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.

Lupus
|April 19, 2007
PubMed

Insights

Anticardiolipin antibodies, linked to thrombosis and atherosclerosis, are prevalent in rheumatoid arthritis (RA) patients. Elevated levels correlate with early atherosclerotic changes in the carotid arteries of RA patients.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is associated with increased atherosclerosis and cardiovascular disease risk.
  • Antiphospholipid antibodies and anti-oxidized LDL (anti-oxLDL) antibodies are implicated in thrombosis and atherosclerosis.
  • Early detection of atherosclerotic changes in RA patients is crucial for cardiovascular risk management.

Purpose of the Study:

  • To investigate the association between antiphospholipid antibodies (anticardiolipin, anti-beta-2-glycoprotein-I) and anti-oxLDL autoantibodies with early atherosclerotic changes in RA patients.
  • To determine if specific autoantibodies are linked to increased carotid artery intima-media thickness (IMT) in RA.
  • To assess the clinical relevance of these autoantibodies in the context of RA-related cardiovascular complications.

Main Methods:

  • Evaluated IgG and IgM anticardiolipin, IgG and IgM anti-beta-2-glycoprotein-I, and anti-oxLDL autoantibody levels in 82 RA patients.
  • Measured carotid artery intima-media thickness (IMT) at the common carotid, bifurcation, and internal carotid arteries.
  • Compared IMT in patients with and without elevated autoantibody levels.

Main Results:

  • Elevated IgG anticardiolipin antibodies were found in 21% of RA patients, with 7 having clinically relevant levels.
  • Patients with elevated IgG anticardiolipin antibodies showed significantly increased mean carotid and carotid bifurcation IMT.
  • No significant association was observed between other tested autoantibodies and increased IMT.

Conclusions:

  • Anticardiolipin antibodies are common in RA and are associated with early atherosclerotic changes.
  • Measuring anticardiolipin antibodies in RA patients may help identify individuals at higher risk for atherosclerosis progression and thrombosis.
  • Targeted treatment upon detection of anticardiolipin antibodies could mitigate cardiovascular risks in RA.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...